Table 1.
Demographic and clinical characteristics of the study participants.
| Characteristics | Overall | Type I | Type IV | p value |
|---|---|---|---|---|
| Gender, n (%) | 69 (100) | 47 (68.1) | 19 (27.5) | 0.947 |
| Female | 51 (73.9) | 35 (68.6) | 14 (27.4) | - |
| Male | 18 (26.1) | 12 (66.7) | 5 (27.8) | - |
| Age at diagnosis (years) | 32 (22–45) | 33 ± 3 | 35 (27–41) | 0.202 |
| Disease course (months) | 72 ± 14 | 66 ± 15 | 93 ± 35 | 0.082 |
| Length of hospital stay (days) | 18 ± 1 | 18 ± 2 | 18 ± 2 | 0.397 |
| Follow-up (months) | 77 ± 8 | 83 ± 11 | 69 ± 12 | 0.677 |
|
| ||||
| Presentation, n (%) | ||||
| Abdominal pain | 62 (89.9) | 43 (69.4) | 17 (27.4) | 1.000 |
| Abdominal mass | 3 (4.3) | 1 (33.3) | 2 (66.7) | 0.197 |
| Jaundice | 18 (26.1) | 13 (72.2) | 4 (22.2) | 0.759 |
| Fever | 21 (30.4) | 15 (71.4) | 5 (23.8) | 0.654 |
| Charcot's triad | 12 (17.4) | 10 (83.3) | 1 (8.3) | 0.156 |
| Nausea/vomit | 29 (42.0) | 18 (62.1) | 10 (34.5) | 0.286 |
| Incidental finding | 7 (10.1) | 4 (57.1) | 2 (28.6) | 1.000 |
| APBJ | 44 (63.8) | 29 (65.9) | 13 (29.5) | 0.607 |
|
| ||||
| Complication, n (%) | 69 (100) | |||
| Malignancy | 5 (7.2) | 2 (40.0) | 3 (60.0) | 0.139 |
| Cholecystolithiasis | 27 (39.1) | 17 (63.0) | 10 (37.0) | 0.218 |
| Choledocholithiasis | 32 (46.4) | 22 (68.8) | 9 (28.1) | 0.967 |
| Cholecystitis | 69 (100) | 47 (68.1) | 19 (27.5) | - |
| Cholangitis | 26 (37.7) | 16 (61.5) | 9 (34.6) | 0.312 |
| Pancreatitis | 15 (21.7) | 9 (60.0) | 5 (33.3) | 0.519 |
APBJ: abnormal pancreaticobiliary junction.